Correlates of epidermal nerve fiber densities in HIV-associated distal sensory polyneuropathy

Objective: To demonstrate the relationship between epidermal nerve fiber density (ENFD) in the leg and the phenotype of HIV-associated distal sensory polyneuropathy (HIV-DSP) in a multicenter prospective study (ACTG A5117). Methods: A total of 101 HIV-infected adults, with CD4 cell count <300 cells/mm3 and who had received antiretroviral therapy (ART) for at least 15 consecutive weeks, underwent standardized clinical and electrophysiologic assessment. All 101 subjects were biopsied at the distal leg (DL) and 99 at the proximal thigh (PT) at baseline. ENFD was assessed by skin biopsy using PGP9.5 immunostaining. Associations of ENFD with demographics, ART treatment, Total Neuropathy Score (TNS), sural sensory nerve action potential (SNAP) amplitude and conduction velocity, quantitative sensory testing (QST) measures, and neuropathic pain were explored. Results: ENFD at the DL site correlated with neuropathy severity as gauged by TNS (p < 0.01), the level of neuropathic pain quantified by the Gracely Pain Scale (GPS) (p = 0.01) and Visual Analogue Scale (VAS) (p = 0.01), sural SNAP amplitude (p < 0.01), and toe cooling (p < 0.01) and vibration (p = 0.02) detection thresholds. ENFD did not correlate with neurotoxic ART exposure, CD4 cell count, or plasma HIV-1 viral load. Conclusions: In subjects with advanced HIV-1 infection, epidermal nerve fiber density (ENFD) assessment correlates with the clinical and electrophysiologic severity of distal sensory polyneuropathy (DSP). ENFD did not correlate with previously established risk factors for HIV-DSP, including CD4 cell count, plasma HIV-1 viral load, and neurotoxic antiretroviral therapy exposure.

[1]  R. Dubner,et al.  Validity and sensitivity of ratio scales of sensory and affective verbal pain descriptors: Manipulation of affect by diazepam , 1978, Pain.

[2]  W. Agras,et al.  A Randomized, Double‐Blind, Placebo‐Controlled: Trial of Trazodone Hydrochloride in Chronic Low Back Pain Syndrome , 1990, Journal of clinical psychopharmacology.

[3]  J. Becker,et al.  Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985-1992. , 1994, Neurology.

[4]  J. Glass,et al.  Peripheral nerve disorders in HIV infection. Similarities and contrasts with CNS disorders. , 1994, Research publications - Association for Research in Nervous and Mental Disease.

[5]  J. McArthur,et al.  Cutaneous innervation in sensory neuropathies , 1995, Neurology.

[6]  J. McArthur,et al.  Intraepidermal nerve fiber density in patients with painful sensory neuropathy , 1997, Neurology.

[7]  C P Das,et al.  Neurological complications of HIV infection. , 1998, Neurology India.

[8]  J. McArthur,et al.  Epidermal nerve fiber density: normative reference range and diagnostic efficiency. , 1998, Archives of neurology.

[9]  T. Crawford,et al.  Small‐fiber sensory neuropathies: Clinical course and neuropathology of idiopathic cases , 1998, Annals of neurology.

[10]  J. McArthur,et al.  Epidermal innervation: changes with aging, topographic location, and in sensory neuropathy , 1999, Journal of the Neurological Sciences.

[11]  H. Nagaraja,et al.  Painful sensory neuropathy , 1999, Neurology.

[12]  J. McArthur,et al.  Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies , 1999, Neurology.

[13]  D. Cornblath,et al.  Total neuropathy score , 1999, Neurology.

[14]  T. Larson,et al.  Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of three cohorts. Nerve growth factor study group. , 2000, Diabetes care.

[15]  L. Wilkins.  A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection , 2000, Neurology.

[16]  D. Katzenstein,et al.  A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection , 2000, Neurology.

[17]  J. Dötsch,et al.  Spontaneous Nocturnal Leptin Secretion in Children with Myelomeningocele and Growth Hormone Deficiency , 2002, Hormone Research in Paediatrics.

[18]  D. Katzenstein,et al.  Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy , 2002, Neurology.

[19]  D. Katzenstein,et al.  Severity of HIV-associated neuropathy is associated with plasma HIV-1 RNA levels , 2002, AIDS.

[20]  D. Pareyson,et al.  Axonal swellings predict the degeneration of epidermal nerve fibers in painful neuropathies , 2003, Neurology.

[21]  M. Mcdermott,et al.  Epidermal nerve fiber density, axonal swellings and QST as predictors of HIV distal sensory neuropathy , 2004, Muscle & nerve.

[22]  EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy. , 2008, European journal of neurology.

[23]  Justin C McArthur,et al.  Another tool for the neurologist's toolbox , 2005, Annals of neurology.

[24]  C. Slotema,et al.  Follow up of patients with signs and symptoms of polyneuropathy not confirmed by electrophysiological studies , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[25]  J. McArthur,et al.  The utility of skin biopsy for prediction of progression in suspected small fiber neuropathy , 2006, Neurology.

[26]  D. Clifford,et al.  HIV neuropathy natural history cohort study , 2006, Neurology.

[27]  M. Mcdermott,et al.  Is skin biopsy a predictor of transition to symptomatic HIV neuropathy? , 2006, Neurology.

[28]  J. McArthur,et al.  Antiretroviral use and other risks for HIV-associated neuropathies in an international cohort , 2006, Neurology.